Stay updated with breaking news from Omicron Specific. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Seoul [South Korea], February 9 (ANI/Global Economic): As the Omicron COVID-19 variant, which is now the most dominant strain in the world, rapidly spread in Korea, SK Bioscience also started developing Omicron-specific vaccines.
As the Omicron COVID-19 variant, which is now the most dominant strain in the world, rapidly spread in Korea, SK Bioscience also started developing Omicron-spec
Moderna, an American pharmaceutical and biotechnology company based in Cambridge on Wednesday (local time) announced that it has begun clinical trials of a booster dose of a vaccine designed specifically to combat the Omicron variant of COVID-19.
India's Gennova working on omicron-specific COVID-19 vaccine
That could be omicron specific. >> we do not yet believe that additional measures will be needed. but, so that we are prepared if needed, my team is already working with the officials at pfizer and moderna and johnson & johnson to develop contingency plans for vaccines or boosters if needed. and i will also direction the fda and the cdc to use the fastest process available without cutting any corners for safety. >> reporter: the president also said that they are throwing everything they have essentially at this effort. of course the white house press secretary jen psaki was just talking about ...